Effects of intracerebroventricular administration of β-funaltrexamine on DAMGO-stimulated [35S]GTP-γ-S binding in rat brain sections

Synapse

Volumn 27, Issue 3, 1997, Pages 177-182

  Martin, Thomas J ^a   Sim, Laura J ^a   Selley, Dana E ^a   DeMontis, M Graziella ^b   Childers, Steve R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Institute of Pharmacology   (Italy)

Author keywords

6 Proteins; GTP S; Opioid receptors

Indexed keywords

BETA FUNALTREXAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; OPIATE RECEPTOR;

ALKYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; REINFORCEMENT;

ANIMALS; BRAIN; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); INJECTIONS, INTRAVENTRICULAR; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, INBRED F344; RECEPTORS, OPIOID, MU; SULFUR RADIOISOTOPES;

EID: 0030883796     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199711)27:3<177::AID-SYN3>3.0.CO;2-A     Document Type: Article

References (26)

1. Adams, J.U., Paronis, C.A., and Holtzman, S.G. (1990) Assessment of relative intrinsic activity of mu opioid analgesics in vivo using β-funaltrexamine. J. Pharmacol. Exp. Ther., 255:1027-1032.
2. 2-agonists in locus coeruleus neurons. Brain Res., 371:390-394.
3. Breivogel, C., Sim, L.J., and Childers, S.R. (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther., in press
4. Burns, D.L., Hewlett, E.L., Moss, J., and Vaughan, M. (1983) Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells., J. Biol. Chem., 258:1435-1438.
5. Childers, S.R. (1991) Opioid receptor-coupled second messengers. Life Sci., 48:1991-2003.
6. m GT-Pase in brain membranes. J. Neurochem., 52:1162-1169.
7. Emmerson, P.J., Clark, M.J., Mansour, A., Akil, H., Woods, J.H., and Medzihrasky, F. (1996) Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the μ opioid receptor. J. Pharmacol. Exp. Ther., 278:1121-1127.
8. Jiang, Q., Seyed-Mozaffari, A., Sebastian, A., Archer, S., and Bidlack, J.M. (1995) Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism. J. Pharmacol. Exp. Ther., 273:680-688.
9. Kurose, H., Katada, T., Amano, T., and Ui, M. (1983) Specific uncoupling by islet-activating, pertussis toxin, of negative signal transduction via α-adrenergic, cholinergic and opiate receptors in neuroblastoma × glioma hybrid cells. J. Biol. Chem., 258:4870-4875.
10. Liu-Chen, L.Y., Yang, H.-H., Li, S., and Adams, J.U. (1995) Effect of intracerebroventricular β-funaltrexamine on μ opioid receptors in the rat brain: Consideration of binding condition. J. Pharmacol. Exp. Ther., 273:1047-1056.
11. Mansour, A., Khachaturian, H., Lewis, M.E., Akil, H., and Watson, S.J. (1988) Anatomy of CNS opioid receptors. Trends Neurol. Sci., 11:308-314.
12. 3H]DAMGO binding to rat brain sections. J. Pharmacol. Exp. Ther., 267:506-514.
13. Martin, T.J., Dworkin, S.I., and Smith, J.E. (1995) Alkylation of mu opioid receptors by β-funaltrexamine in vivo: Comparison of the effects on in situ binding and heroin self-administration in rats. J. Pharmacol. Exp. Ther., 272:1135-1140.
14. North, R.A., Williams, J.T., Surprenant, A., and Christie, M.J. (1987) μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. U.S.A. 84:5487-5491.
15. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, San Diego, CA.
16. Rothman, R.B., Long, J.B., Bykov, V., Jacobsen, A.E., Rice, K.R., and Holaday, J.W. (1988) β-FNA binds irreversibly to the opiate receptor complex: In vitro and in vivo evidence. J. Pharmacol. Exp. Ther., 247:405-416.
17. m GTPase studies. J. Pharmacol. Exp. Ther., 263:99-104.
18. 35S]GTP-γS binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. Mol. Pharmacol., 51:87-96.
19. 35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. U.S.A. 92:7242-7246.
20. 35S]GTP-γS autoradiography in rat brain. J. Neurosci., 16:2684-2692.
21. Sim, L.J., Selley, D.E., Xiao, R., and Childers, S.R. (1996b) Differences in G-protein activation by mu and delta opioid, and cannabinoid, receptors in rat striatum. Eur. J. Pharmacol., 307:95-107.
22. Takemori, A.E., Larson, D.L., and Portoghese, P.S. (1981) The irreversible narcotic antagonistic and reversible agonistic properties of the fumarate methyl ester derivative of naltrexone. Eur. J. Pharmacol., 70:445-451.
23. Tempel, A. and Zukin, R.S. (1987) Neuroanatomical patterns of the μ, δ, and K opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci., 84:4308-4312.
24. Tam, W.S., and Liu-Chen, L.-Y. (1986) Reversible and irreversible binding of β-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. J. Pharmacol. Exp. Ther., 239:351-357.
25. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 47:848-854.
26. Ward, S.J., Fries, D.S., Larson, D.L., Portoghese, P.S., and Takemori, A.E. (1985) Opioid receptor binding characteristics of the non-equilibrium μ antagonist, β-funaltrexamine (β-FNA). Eur. J. Pharmacol., 107:323-330.